HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral efficacy of WIN 51711 in mice infected with human poliovirus.

Abstract
WIN 51711, a new broad-spectrum anti-picornavirus agent, prevented the development of paralysis and subsequent death in mice infected intracerebrally with a lethal dose of human poliovirus type 2 (MEF strain). The prophylactic efficacy of intragastrically administered WIN 51711 was dose dependent over the 3.9- to 62.5-mg/kg (twice daily) dose range, with a minimal significantly effective dose of less than 15.6 mg/kg per dose (twice daily) (P less than 0.008). An oral four times a day dosage regimen initiated 48 h postinfection with WIN 51711 doses as low as 12.5 mg/kg was effective in significantly reducing poliovirus-induced paralysis and death compared with a placebo. Viral titers in the brains and spines of mice infected intracerebrally with 200 50% lethal doses of poliovirus were reduced by 3 to 5 log10 PFU/g in the WIN 51711-medicated group compared with placebo-medicated animals. The potent in vitro and in vivo anti-picornavirus activity of WIN 51711 makes it a potentially useful drug for the treatment of enterovirus infections in humans.
AuthorsM A McKinlay, B A Steinberg
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 29 Issue 1 Pg. 30-2 (Jan 1986) ISSN: 0066-4804 [Print] United States
PMID3729333 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Isoxazoles
  • Oxazoles
  • disoxaril
Topics
  • Animals
  • Antiviral Agents (therapeutic use)
  • Brain (microbiology)
  • Female
  • Humans
  • Isoxazoles (therapeutic use)
  • Mice
  • Mice, Inbred ICR
  • Oxazoles (therapeutic use)
  • Poliomyelitis (drug therapy, microbiology, prevention & control)
  • Spinal Cord (microbiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: